LBO-002 Treatment with resmetirom for up to two years led to improvement in liver stiffness, fibrosis biomarkers, fibrosis scores and portal hypertension risk in 122 patients with compensated MASH cirrhosis

Journal article

Peer reviewed

Naim Alkhouri, Rebecca Taub, Xiaomin Lu, Richard Pushkin, Michael R. Charlton, Sam Moussa, Anita Kohli, Mazen Noureddin and Jörn M. Schattenberg

Journal of hepatology, Vol.82, pp.S9-S10

05/2025

Metrics

1 Record Views

Title: LBO-002 Treatment with resmetirom for up to two years led to improvement in liver stiffness, fibrosis biomarkers, fibrosis scores and portal hypertension risk in 122 patients with compensated MASH cirrhosis
Creators: Naim Alkhouri
Rebecca Taub
Xiaomin Lu
Richard Pushkin
Michael R. Charlton
Sam Moussa
Anita Kohli
Mazen Noureddin
Jörn M. Schattenberg
Publication Details: Journal of hepatology, Vol.82, pp.S9-S10
Identifiers: 991006167221802656
Academic Unit: Internal Medicine
Language: English
Resource Type: Journal article